Recent PSNL News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:11:58 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:07:10 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:03:19 PM
- Personalis to Participate in the 25th Annual Needham Virtual Conference • Business Wire • 04/01/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:57:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:54:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 08:17:21 PM
- Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption • Business Wire • 03/17/2026 08:00:00 PM
- Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® • Business Wire • 03/12/2026 10:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2026 10:11:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:05:35 PM
- Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights • Business Wire • 02/26/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2026 11:50:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2026 11:48:57 PM
- Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference • Business Wire • 02/17/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 10:24:46 PM
- Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 02/12/2026 09:01:00 PM
- Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance • Business Wire • 02/10/2026 11:00:00 AM
- Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors • Business Wire • 02/02/2026 11:00:00 AM
- Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference • Business Wire • 01/28/2026 09:01:00 PM
- Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™ • Business Wire • 01/12/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:05:26 PM
- Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights • Business Wire • 01/08/2026 01:00:00 PM
- Smart Oncology: 5 Stocks Chasing the $317B Prize • PR Newswire (Canada) • 12/31/2025 12:25:00 PM
